Combination of intrahepatic TARE and extrahepatic TACE to treat HCC patients with extrahepatic artery supply: A case series-Reference-Cited by-同舟云学术

Combination of intrahepatic TARE and extrahepatic TACE to treat HCC patients with extrahepatic artery supply: A case series

Published:2024-03 Issue: Volume:9 Page:100042
ISSN:2772-6525
Container-title:Research in Diagnostic and Interventional Imaging
language:en
Short-container-title:Research in Diagnostic and Interventional Imaging

Author:

Pescatori Lorenzo Carlo,Galletto Pregliasco Athena,Derbel Haytham,Saccenti Laetitia,Ghosn Mario,Blain Maxime,Chalayea Julia,Luciani Alain,Mulé Sebastien,Amaddeo Giuliana,Kobeiter Hicham,Tacher Vania

Publisher

Elsevier BV

Reference27 articles.

1. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Vogel;Ann Oncol,2018

2. National Institute for Health and Care Excellence (NICE) (2021) Selective internal radiation therapies for treating hepatocellular carcinoma (NICE technology appraisal guidance TA688). https://www.nice.org.uk/guidance/ta688/resources/selective-internal-radiation-therapies-for-treating-hepatocellular-carcinoma-pdf-82609386772165.

3. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study;Kim;Lancet Gastroenterol Hepatol,2022

4. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial;Garin;Lancet Gastroenterol Hepatol,2021

5. Intraarterial treatment of hepatocellular carcinoma: comparison of MELD score variations between radioembolization and chemo-embolization;Delicque;Diagn Interv Imaging,2019